UTI Mutual FundEquity Schemes - Thematic Fund3 years
The scheme seeks to provide medium to long-term capital appreciation through investment primarily in growth and innovation-oriented equity and equity-related instruments.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Recent return trails the category median by 3 percentage points or more, with a weak rolling win rate.
Fits if · Three-year return sits below the 25th percentile of comparable share classes.
Prefer peers if · Prefer 360 ONE QUANT FUND if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.0 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
1.24% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -31.5%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Nitin Jain · 2.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 54.6% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 32%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
Path not in current snapshots
n/a
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
Path not in current snapshots
n/a
23 Sept 2024 – open
Trough 23 Mar 2026 · not recovered
-31.5%
31 Jan 2024 – 8 Apr 2024
Trough 13 Mar 2024 · recovered in 26 days
-9.3%
8 Apr 2024 – 13 Jun 2024
Trough 4 Jun 2024 · recovered in 9 days
-8.4%
2 Aug 2024 – 12 Aug 2024
Trough 6 Aug 2024 · recovered in 6 days
-4.7%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
3
Vs category
27
Consistency
2
Risk-adjusted
25
Drawdown
21
Mean
16
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 34 holdings · top 10 are 54.6%.
Zomato Ltd
Technology
9.4%
Info Edge (India) Ltd
Technology
9.1%
FSN E-Commerce Ventures Ltd
Consumer Discretionary
6.2%
Affle (India) Ltd
Industrials
5.7%
Ami Organics Ltd
Healthcare
4.9%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026
Same-category peers with enough history to inspect beside this fund - including tradeoffs.
360 ONE Mutual Fund
HSBC Mutual Fund
Invesco Mutual Fund
Mahindra Manulife Mutual Fund
Nippon India Mutual Fund
UTI Mutual FundEquity Schemes - Thematic Fund3 years
The scheme seeks to provide medium to long-term capital appreciation through investment primarily in growth and innovation-oriented equity and equity-related instruments.
Buying brief
Evidence on this desk, framed as a purchase checklist - not SEBI-registered advice.
As of 29 Oct 2026
Stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
In three lines
Fits if · Recent return trails the category median by 3 percentage points or more, with a weak rolling win rate.
Fits if · Three-year return sits below the 25th percentile of comparable share classes.
Prefer peers if · Prefer 360 ONE QUANT FUND if you want a same-category peer with stronger evidence.
Buy checklist
History depth
Watch
3.0 years - usable, still building a track record.
Engine status
Watch
Recent evidence is mixed. Compare peers before increasing exposure.
Expense ratio
Pass
1.24% TER (Direct). Lower cost compounds on long SIPs.
Drawdown vs peers
Pass
Peak-to-trough -31.5%. Ask whether you can hold through a similar fall.
Vs category
Fail
0% of rolling 3Y windows beat the category median, same plan and option.
Manager tenure
Pass
Nitin Jain · 2.1 years on the scheme.
Exit load
n/a
No exit-load summary on file.
Tax / wrapper
Pass
Direct Growth, no ELSS lock flagged. Equity LTCG rules still apply after one year - not tax advice.
Portfolio concentration
Pass
Top 10 holdings ≈ 54.6% of the portfolio.
Same-category peers are preloaded into compare when available.
Behaviour and wrappers - the usual India MF failure modes - not a buy instruction.
Drawdown rehearsal
This scheme’s worst fall on file is about 32%. Before you SIP, ask whether you would keep contributing through a similar drop - pausing on fear is the usual India MF failure mode.
SIP discipline
Monitor is recent mixed evidence - keep the SIP unless the buying brief says prefer peers, then swap with intent.
NAV
29 Oct 2026 · -8.1% over 1Y
11.3308
Trailing CAGR and simulated monthly SIP XIRR from daily NAV. Category comparison uses the median of comparable share classes in the peer set.
Trailing CAGR
Point-to-point, calendar-day annualized
SIP XIRR
Equal monthly instalments to latest NAV
Date-aligned against NIFTY 500 TRI. Capture ratios use common month-end observations through 30 Oct 2026.
Peak to trough from a running NAV high, with the path and recovery episodes.
Drawdown
29 Oct 2026
-15.6%
23 Sept 2024 – open
Trough 23 Mar 2026 · not recovered
-31.5%
31 Jan 2024 – 8 Apr 2024
Trough 13 Mar 2024 · recovered in 26 days
-9.3%
8 Apr 2024 – 13 Jun 2024
Trough 4 Jun 2024 · recovered in 9 days
-8.4%
2 Aug 2024 – 12 Aug 2024
Trough 6 Aug 2024 · recovered in 6 days
-4.7%
0–100 reads of named metrics. The mean is unweighted and only uses dimensions with data.
Returns
3
Vs category
27
Consistency
2
Risk-adjusted
25
Drawdown
21
Mean
16
Quantitative engine reasons behind the buying stance. An explanation can only restate what is already here.
Buying stance
Watch before adding
Recent evidence is mixed. Compare peers before increasing exposure.
Why this status
Supporting reads
No supporting reads in the current evidence set.
30 Sept 2026 · 34 holdings · top 10 are 54.6%.
Zomato Ltd
Technology
9.4%
Info Edge (India) Ltd
Technology
9.1%
FSN E-Commerce Ventures Ltd
Consumer Discretionary
6.2%
Affle (India) Ltd
Industrials
5.7%
Ami Organics Ltd
Healthcare
4.9%
PERFORMANCE
Recent rolling excess versus the category median has deteriorated.
19 Oct 2026